{"id":27108,"date":"2012-02-04T07:15:04","date_gmt":"2012-02-04T12:15:04","guid":{"rendered":"http:\/\/countingpips.com\/fx\/2012\/02\/04\/allergan-reports-inline-results-and-gives-mixed-guidance\/"},"modified":"2012-02-04T07:15:04","modified_gmt":"2012-02-04T12:15:04","slug":"allergan-reports-inline-results-and-gives-mixed-guidance","status":"publish","type":"post","link":"https:\/\/www.investmacro.com\/fx\/2012\/02\/04\/allergan-reports-inline-results-and-gives-mixed-guidance\/","title":{"rendered":"Allergan Reports Inline Results And Gives Mixed Guidance"},"content":{"rendered":"<p><div id=\"grabDiv1767162\"><object id=\"GrabPlayer1767162\" width=\"540\" height=\"300\" type=\"application\/x-shockwave-flash\" align=\"middle\" data=\"http:\/\/player.grabnetworks.com\/swf\/GrabOSMFPlayer.swf?id=1767162&#038;content=v09c3f2df3f390d6868f8166ff972ba17d0bec6ae&#038;tgt=grabnetworks\"><param name=\"quality\" value=\"high\"\/><param name=\"allowScriptAccess\" value=\"always\"\/><param name=\"allowFullScreen\" value=\"true\"\/><param name=\"menu\" value=\"false\"\/><param name=\"movie\" value=\"http:\/\/player.grabnetworks.com\/swf\/GrabOSMFPlayer.swf?id=1767162&#038;content=v09c3f2df3f390d6868f8166ff972ba17d0bec6ae&#038;tgt=grabnetworks\"\/><\/object><\/div>\n<\/p>\n<p>Allergan (NYSE:AGN) reported Q4 EPS of $1.00, inline with estimates. Revenues came in at $1.4 billion, which was also inline with estimates as well.Allergan said it sees 2012 EPS of $4.13 &#8211; $4.19, vs. estimates of $4.21.The company sees Q1 EPS of $0.84 &#8211; $0.86, vs. estimates of $0.91 and said it sees 2012 product sales of $5.65 billion &#8211; $5.85 billion, vs. estimates of $5.89 billion.<\/p>\n<p><img src='http:\/\/cache.thenewsroom.com\/financial_news_network\/2012\/02\/04\/1_7fyr74to_thumb.jpg' \/><\/p>\n<p><!--post_img[http:\/\/cache.thenewsroom.com\/financial_news_network\/2012\/02\/04\/1_7fyr74to_preview.jpg]--><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Allergan (NYSE:AGN) reported Q4 EPS of $1.00, inline with estimates. Revenues came in at $1.4 billion, which was also inline with estimates as well.Allergan said it sees 2012 EPS of $4.13 &#8211; $4.19, vs. estimates of $4.21.The company sees Q1 EPS of $0.84 &#8211; $0.86, vs. estimates of $0.91 and said it sees 2012 product &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.investmacro.com\/fx\/2012\/02\/04\/allergan-reports-inline-results-and-gives-mixed-guidance\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Allergan Reports Inline Results And Gives Mixed Guidance&#8221;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-27108","post","type-post","status-publish","format-standard","hentry"],"_links":{"self":[{"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/posts\/27108","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/comments?post=27108"}],"version-history":[{"count":0,"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/posts\/27108\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/media?parent=27108"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/categories?post=27108"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/tags?post=27108"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}